Breaking News Instant updates and real-time market news.

NHI

National Health Investors

$75.55

0.18 (0.24%)

06:02
08/09/17
08/09
06:02
08/09/17
06:02

National Health Investors reports Q2 EPS 93c, consensus 87c

Reports Q2 revenue $69.84M, consensus $68.41M. Reports Q2 normalized AFFO up 7.3% y-o-y to $1.18.

  • 09

    Aug

  • 19

    Sep

NHI National Health Investors
$75.55

0.18 (0.24%)

05/22/17
BOFA
05/22/17
DOWNGRADE
Target $76
BOFA
Underperform
National Health Investors downgraded to Underperform at BofA/Merrill
BofA/Merrill analyst Juan Sanabria downgraded National Health Investors to Underperform from Neutral citing valuation and maintained its $76 price target. The analyst said National's triple-net senior housing has some of the weakest demographics versus peers and its secondary focus leaves it more exposed to supply versus peers.
11/14/16
SPHN
11/14/16
NO CHANGE
Target $78
SPHN
Overweight
National Health Investors price target lowered to $78 from $84 at Stephens
Stephens analyst Dana Hambly lowered his price target for National Health Investors to $78 from $84 after the company reported a headline normalized funds from operations miss that was driven by a higher than expected share count. The analyst reiterates an Overweight rating on the shares.
09/14/16
SPHN
09/14/16
INITIATION
Target $84
SPHN
Overweight
National Health Investors initiated with an Overweight at Stephens
Stephens analyst Dana Hambly initiated National Health Investors with an Overweight rating and $84 price target.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.